These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 15205083

  • 1. Safety profiles of Fe2+ and Fe3+ oral preparations in the treatment of iron deficiency anemia in children.
    Kavakli K, Yilmaz D, Cetinkaya B, Balkan C, Sözmen EY, Sağin FG.
    Pediatr Hematol Oncol; 2004; 21(5):403-10. PubMed ID: 15205083
    [Abstract] [Full Text] [Related]

  • 2. Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia.
    Aycicek A, Koc A, Oymak Y, Selek S, Kaya C, Guzel B.
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):57-61. PubMed ID: 23743961
    [Abstract] [Full Text] [Related]

  • 3. Malondialdehyde, antioxidant enzymes, and renal tubular functions in children with iron deficiency or iron-deficiency anemia.
    Altun D, Kurekci AE, Gursel O, Hacıhamdioglu DO, Kurt I, Aydın A, Ozcan O.
    Biol Trace Elem Res; 2014 Oct; 161(1):48-56. PubMed ID: 25099508
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children.
    Bopche AV, Dwivedi R, Mishra R, Patel GS.
    Indian Pediatr; 2009 Oct; 46(10):883-5. PubMed ID: 19430060
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron].
    Casparis D, Del Carlo P, Branconi F, Grossi A, Merante D, Gafforio L.
    Minerva Ginecol; 1996 Nov; 48(11):511-8. PubMed ID: 9005381
    [Abstract] [Full Text] [Related]

  • 12. Effects of a Tripeptide Iron on Iron-Deficiency Anemia in Rats.
    Xiao C, Lei X, Wang Q, Du Z, Jiang L, Chen S, Zhang M, Zhang H, Ren F.
    Biol Trace Elem Res; 2016 Feb; 169(2):211-7. PubMed ID: 26109335
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Superoxide dismutase and glutathione peroxidase in erythrocytes of patients with iron deficiency anemia: effects of different treatment modalities.
    Isler M, Delibas N, Guclu M, Gultekin F, Sutcu R, Bahceci M, Kosar A.
    Croat Med J; 2002 Feb; 43(1):16-9. PubMed ID: 11828552
    [Abstract] [Full Text] [Related]

  • 15. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
    Prats M, Font R, García C, Muñoz-Cortés M, Cabré C, Jariod M, Romeu M, Giralt M, Martinez-Vea A.
    Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative evaluation of efficacy and tolerance of iron polymaltose complex and ferrous sulphate for treatment of iron deficiency anemia in infants].
    Amaral D, Galimberti G, Cuesta S, Pinto J, Ferrario C, Graciela E.
    Rev Fac Cien Med Univ Nac Cordoba; 2012 Jun; 69(2):97-101. PubMed ID: 23286539
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.